Sculptra™...
a sculpting agent that restores volume to correct the signs of facial fat loss

Sculptra™ is approved by the US Food and Drug Administration (FDA) for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.

Facial fat loss, or lipoatrophy, is the loss of fat beneath the skin, which can result in sunken cheeks, indentations, and hollow eyes. Sculptra™ is a safe, synthetic, and biocompatible material that is injected below the surface of the skin in the area of fat loss. It provides a gradual and significant increase in skin thickness, improving the appearance of folds and sunken areas. No skin testing is required.

Poly-L-lactic acid has been safely used outside the United States since 1999 in over 150,000 patients under the trade name New-Fill™.

We are involved in the FDA Phase 3 clinical trial of Sculptra for cosmetic use. Come in and talk to us about treatment.